- Sections
- C - Chimiemétallurgie
- C40B - Chimie combinatoirebibliothèques, p. ex. chimiothèques
- C40B 30/08 - Procédés de criblage des bibliothèques en mesurant l'activité catalytique
Détention brevets de la classe C40B 30/08
Brevets de cette classe: 73
Historique des publications depuis 10 ans
|
8
|
2
|
3
|
2
|
10
|
3
|
2
|
2
|
1
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| HTE GmbH The High Throughput Experimentation Company | 62 |
5 |
| 1859, Inc. | 15 |
5 |
| The Regents of the University of California | 21018 |
3 |
| Novozymes A/S | 3408 |
3 |
| Hypharm GmbH | 12 |
3 |
| The Board of Trustees of the Leland Stanford Junior University | 6754 |
2 |
| National Taiwan University | 1342 |
2 |
| Ginkgo BioWorks, Inc. | 261 |
2 |
| Institute of Microbiology, Chinese Academy of Sciences | 142 |
2 |
| National Health Research Institutes | 334 |
2 |
| The Trustees of Princeton University | 1287 |
2 |
| Cyclenium Pharma Inc. | 8 |
2 |
| Merck Patent GmbH | 5772 |
1 |
| Glaxosmithkline Intellectual Property Development Limited | 785 |
1 |
| California Institute of Technology | 4050 |
1 |
| Life Technologies Corporation | 3629 |
1 |
| The Johns Hopkins University | 5972 |
1 |
| President and Fellows of Harvard College | 6129 |
1 |
| Affinity Biosciences Pty Ltd | 10 |
1 |
| AV Therapeutics, Inc. | 2 |
1 |
| Autres propriétaires | 32 |